RhumbLine Advisers’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$748K Buy
498,861
+1,621
+0.3% +$2.07K ﹤0.01% 2506
2026
Q1
$567K Sell
497,240
-14,239
-3% -$17.5K ﹤0.01% 2537
2025
Q4
$644K Sell
511,479
-43,903
-8% -$61.1K ﹤0.01% 2507
2025
Q3
$861K Buy
555,382
+25,829
+5% +$35.5K ﹤0.01% 2328
2025
Q2
$699K Buy
529,553
+39,274
+8% +$53.7K ﹤0.01% 2446
2025
Q1
$814K Sell
490,279
-28,544
-6% -$47K ﹤0.01% 2273
2024
Q4
$763K Sell
518,823
-27,794
-5% -$42.5K ﹤0.01% 2394
2024
Q3
$814K Sell
546,617
-55,478
-9% -$82.3K ﹤0.01% 2374
2024
Q2
$753K Sell
602,095
-65,331
-10% -$84.7K ﹤0.01% 2403
2024
Q1
$801K Buy
667,426
+17,409
+3% +$17.4K ﹤0.01% 2378
2023
Q4
$982K Buy
650,017
+1,132
+0.2% +$1.64K ﹤0.01% 2260
2023
Q3
$1.04M Buy
648,885
+181
+0% +$330 ﹤0.01% 2186
2023
Q2
$1.41M Sell
648,704
-13,959
-2% -$21.8K ﹤0.01% 2110
2023
Q1
$967K Buy
662,663
+19,284
+3% +$24.8K ﹤0.01% 2136
2022
Q4
$804K Sell
643,379
-5,327
-0.8% -$8.39K ﹤0.01% 2249
2022
Q3
$1.23M Buy
648,706
+42,521
+7% +$101K ﹤0.01% 2032
2022
Q2
$1.53M Buy
606,185
+53,396
+10% +$156K ﹤0.01% 1912
2022
Q1
$1.9M Sell
552,789
-63,092
-10% -$223K ﹤0.01% 1843
2021
Q4
$2.96M Sell
615,881
-4,975
-0.8% -$20.1K ﹤0.01% 1670
2021
Q3
$2.27M Buy
620,856
+18,201
+3% +$67.7K ﹤0.01% 1841
2021
Q2
$2.44M Sell
602,655
-72,671
-11% -$285K ﹤0.01% 1849
2021
Q1
$2.9M Sell
675,326
-38,575
-5% -$184K ﹤0.01% 1729
2020
Q4
$2.82M Buy
713,901
+83,153
+13% +$347K ﹤0.01% 1673
2020
Q3
$2.33M Sell
630,748
-88,290
-12% -$373K ﹤0.01% 1589
2020
Q2
$2.45M Buy
719,038
+76,646
+12% +$172K ﹤0.01% 1612
2020
Q1
$861K Buy
642,392
+60,898
+10% +$95.4K ﹤0.01% 1943
2019
Q4
$855K Buy
581,494
+30,997
+6% +$51.9K ﹤0.01% 2150
2019
Q3
$1.15M Buy
550,497
+53,557
+11% +$109K ﹤0.01% 1973
2019
Q2
$1.21M Buy
496,940
+25,594
+5% +$55.8K ﹤0.01% 1980
2019
Q1
$1.23M Sell
471,346
-4,504
-0.9% -$13.6K ﹤0.01% 1939
2018
Q4
$1.43M Buy
475,850
+137,968
+41% +$468K ﹤0.01% 1836
2018
Q3
$1.17M Buy
337,882
+714
+0.2% +$3.79K ﹤0.01% 1934
2018
Q2
$1.58M Buy
337,168
+19,316
+6% +$73.3K ﹤0.01% 1798
2018
Q1
$1.01M Sell
317,852
-6,261
-2% -$25.2K ﹤0.01% 1943
2017
Q4
$1.59M Sell
324,113
-3,458
-1% -$20.1K ﹤0.01% 1748
2017
Q3
$2.25M Buy
327,571
+343
+0.1% +$2.16K ﹤0.01% 1536
2017
Q2
$2.15M Sell
327,228
-45,022
-12% -$316K ﹤0.01% 1534
2017
Q1
$2.98M Buy
372,250
+14,377
+4% +$121K 0.01% 1325
2016
Q4
$3.33M Buy
357,873
+27,652
+8% +$286K 0.01% 1152
2016
Q3
$3.5M Buy
330,221
+17,101
+5% +$170K 0.01% 1082
2016
Q2
$2.92M Buy
313,120
+35,460
+13% +$360K 0.01% 1132
2016
Q1
$2.88M Sell
277,660
-6,288
-2% -$57.4K 0.01% 1142
2015
Q4
$2.85M Buy
283,948
+2,129
+0.8% +$21.3K 0.01% 1140
2015
Q3
$2.37M Buy
281,819
+71,486
+34% +$946K 0.01% 1223
2015
Q2
$3.38M Buy
210,333
+5,298
+3% +$82.4K 0.01% 1080
2015
Q1
$2.9M Buy
205,035
+30,650
+18% +$399K 0.01% 1152
2014
Q4
$1.74M Sell
174,385
-4,437
-2% -$38K 0.01% 1440
2014
Q3
$1.52M Sell
178,822
-85
-0% -$747 ﹤0.01% 1505
2014
Q2
$1.58M Buy
178,907
+15,343
+9% +$134K ﹤0.01% 1529
2014
Q1
$1.52M Sell
163,564
-7,020
-4% -$61.5K ﹤0.01% 1525
2013
Q4
$1.44M Buy
170,584
+9,350
+6% +$94.5K ﹤0.01% 1569
2013
Q3
$1.42M Buy
161,234
+11,745
+8% +$94.2K ﹤0.01% 1542
2013
Q2
$1.06M Buy
+149,489
New +$1.03M ﹤0.01% 1718

Other funds holding OPK

RhumbLine Advisers's OPK Position: Q2 2026 in Review

RhumbLine Advisers increased its Opko Health (OPK) stake by 0.33% in Q2 2026, buying an estimated $2.07K and bringing the position to 498,861 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

RhumbLine Advisers first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.5M in Q3 2016. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • RhumbLine Advisers held 498,861 shares of Opko Health worth $748K as of Q2 2026.
  • RhumbLine Advisers bought 1,621 Opko Health shares in Q2 2026, an estimated $2.07K.
  • Opko Health made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2506 holding.
  • RhumbLine Advisers first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Opko Health position peaked at $3.5M in Q3 2016.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.